TANG CAPITAL MANAGEMENT LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 78 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2021. The put-call ratio across all filers is 2.29 and the average weighting 1.3%.

Quarter-by-quarter ownership
TANG CAPITAL MANAGEMENT LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$30,649,000
-25.3%
9,607,9340.0%4.65%
-43.3%
Q1 2022$41,026,000
-8.2%
9,607,9340.0%8.21%
-8.7%
Q4 2021$44,677,000
+11.4%
9,607,934
-4.4%
8.98%
+7.9%
Q3 2021$40,096,000
-6.8%
10,049,2240.0%8.32%
-2.8%
Q2 2021$43,011,000
+7.9%
10,049,224
+6.8%
8.56%
-23.7%
Q1 2021$39,879,000
+9.3%
9,405,4900.0%11.22%
+101.4%
Q4 2020$36,493,000
-3.7%
9,405,4900.0%5.57%
-18.8%
Q3 2020$37,904,000
+2.3%
9,405,490
+8.2%
6.86%
+90.4%
Q2 2020$37,043,000
+9.2%
8,695,474
+7.6%
3.60%
-24.4%
Q1 2020$33,937,000
+74.8%
8,080,345
+63.6%
4.76%
+105.5%
Q4 2019$19,410,000
-55.3%
4,938,8930.0%2.32%
-68.8%
Q3 2019$43,462,000
-4.9%
4,938,8930.0%7.44%
+20.4%
Q2 2019$45,685,000
+43.9%
4,938,8930.0%6.17%
+5.5%
Q1 2019$31,757,000
-13.2%
4,938,893
+27.3%
5.85%
-30.3%
Q4 2018$36,578,000
-56.1%
3,878,893
-6.3%
8.39%
-38.3%
Q3 2018$83,316,000
-31.0%
4,138,8930.0%13.60%
-11.1%
Q2 2018$120,732,000
-2.0%
4,138,8930.0%15.30%
-15.5%
Q1 2018$123,256,000
+11.3%
4,138,893
+20.3%
18.11%
+3.3%
Q4 2017$110,713,000
-7.5%
3,440,4190.0%17.54%
-52.0%
Q3 2017$119,658,000
+16.8%
3,440,4190.0%36.54%
+0.5%
Q2 2017$102,421,000
-0.3%
3,440,4190.0%36.35%
-2.1%
Q1 2017$102,697,000
+83.6%
3,440,419
+7.8%
37.12%
+24.4%
Q4 2016$55,941,000
-26.3%
3,191,1650.0%29.83%
-5.3%
Q3 2016$75,918,000
+55.5%
3,191,165
+4.6%
31.49%
+44.7%
Q2 2016$48,834,000
-23.5%
3,052,1300.0%21.76%
-25.1%
Q1 2016$63,820,000
-17.7%
3,052,130
+6.3%
29.06%
-5.6%
Q4 2015$77,548,000
-4.3%
2,872,130
-1.5%
30.77%
+3.0%
Q3 2015$81,007,000
+24.0%
2,914,970
+9.4%
29.87%
+50.7%
Q2 2015$65,318,000
+66.4%
2,664,970
+24.3%
19.82%
-5.1%
Q1 2015$39,242,000
-0.8%
2,144,3870.0%20.87%
-3.8%
Q4 2014$39,564,000
+115.4%
2,144,387
+12.2%
21.69%
+127.9%
Q3 2014$18,369,000
+126.9%
1,911,462
+116.7%
9.52%
+153.9%
Q2 2014$8,096,000
+6590.9%
881,907
+7760.8%
3.75%
+6254.2%
Q1 2014$121,00011,2190.06%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders